DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Radiation Omission in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results Sep 15, 2023
Leukemia,Lymphoma Ven-obi Regimen Proves Effective For Patients With Previously Untreated CLL And Coexisting Conditions Sep 15, 2023
Lymphoma,MCL (Mantle Cell Lymphoma) MRD-driven Ibrutinib Discontinuation Shows Prolonged Undetectable MRD Sep 15, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma pola-R-miniCHP Shows Tolerability As A Potential Primary Treatment For Elderly DLBCL Pts Sep 13, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Glofitamab + Polatuzumab Show Durable Responses In R/R DLBCL With Manageable Safety Profile Sep 11, 2023
Lymphoma Glofitamab Monotherapy Demonstrates Durable Responses In Patients With R/R LBCL Sep 11, 2023
DLBCL (Diffuse Large B Cell Lymphoma) Results for Anti-CD19 Allogeneic Car T in R/R LBCL Sep 08, 2023
